Ambeed.cn

首页 / / / / Nelfinavir

那非那韦 /Nelfinavir {[allProObj[0].p_purity_real_show]}

货号:A128893 同义名: 奈非那韦 / AG1341

Nelfinavir is a selective and potent HIV-1 protease inhibitor used in combination with other antiviral drugs in the treatment of HIV.

Nelfinavir 化学结构 CAS号:159989-64-7
Nelfinavir 化学结构
CAS号:159989-64-7
Nelfinavir 3D分子结构
CAS号:159989-64-7
Nelfinavir 化学结构 CAS号:159989-64-7
Nelfinavir 3D分子结构 CAS号:159989-64-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Nelfinavir 纯度/质量文件 产品仅供科研

货号:A128893 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >
产品名称 HIV Protease HIV-1 caspid 其他靶点 纯度
Dextran sulfate sodium, mw 40,000 M.W 40000
Vicriviroc maleate 98+%
Rosamultin 97%
Darunavir 98%
Lopinavir ++++

HIV protease, Ki: 1.3 pM

99+%
Chloroquine Autophagy 95%
Amprenavir +

HIV protease, IC50: 14.6 ng/mL

PXR 99%+
NBD-556 99%+
Nelfinavir Mesylate +++

HIV protease, Ki: 2 nM

99%+
Atazanavir Sulfate 98%
Limonin 98%
Saquinavir ++

HIV proteinase, IC50: 2.7 nM

98%
Ritonavir 98%
Azvudine 98%
Lenacapavir ++++

HIV-1 capsid, EC50: 0.1 nM

97%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Nelfinavir 生物活性

描述 The HIV-1 protease belongs to the family of aspartyl protease. It cleaves the newly synthesized polyproteins, which is the vital step to create the mature protein components of an infectious HIV-1 virus[3]. Nelfinavir is a selective, nonpeptidic competitive inhibitor of the HIV-1 protease{{Kaldor SW, Kalish VJ, Davies JF II, et al. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem 1997 Nov 21; 40: 3979-85.|https://pubmed.ncbi.nlm.nih.gov/9397180/}}. Nelfinavir has an in vitro inhibition constant(Ki) of 1.7 nM against HIV-1 protease, but no significant activity against human aspartic proteases including pepsin, renin and gastricin. Very weak affinity for cathepsin E (74 μM) and cathepsin D (435 nM) has been observed. The mean nelfinavir concentration producing 95% inhibition of viral replication (IC95) in a variety of i in vitro HIV infection models was 59 nM (range 7 to 130 nM). Nelfinavir was also effective at inhibiting replication of the zidovudine-resistant HIV-1 strain G910-6 and the NNRTI-resistant strain A17[4]. The mean plasma nelfinavir concentration exceeded the 95% antiviral effective dose (ED95 =40 μg/L) for up to 8 hours after a single 100mg dose, and up to 24 hours after an 800mg dose. The area under the concentration-time curve (AUC) after administration in the fasted state was 27 to 50% of the AUC when the drug was administered with food[5]. Nelfinavir is metabolised in the liver by the cytochrome P450 (CYP) enzyme system. Nelfinavir is metabolically converted to its major hydroxy-t-butylamide metabolite M8, which has anti-HIV activity comparable to nelfinavir i in vitro [6].

Nelfinavir 临床研究

NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00624195 HIV Infections Phase 2 Phase 3 Completed - United States, California ... 展开 >> HIV Neurobehavioral Research Center, University of California San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins University- School of Medicine Baltimore, Maryland, United States, 21287 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York Mount Sinai Medical Center New York, New York, United States, 10024 收起 <<
NCT00002411 HIV Infections Not Applicable Completed - -
NCT00624195 - Completed - -

Nelfinavir 参考文献

[1]Mondal D, Liu K, et al. Nelfinavir suppresses insulin signaling and nitric oxide production by human aortic endothelial cells: protective effects of thiazolidinediones. Ochsner J. 2013 Spring;13(1):76-90.

[2]Kaldor SW, Kalish VJ, et al. Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease. J Med Chem. 1997 Nov 21;40(24):3979-85.

[3]Davies, D. R. The structure and function of the aspartic proteinases. Annu. Rev. Biophys. Biophys. Chem. 19, 189–215,

[4]A K Patick,et al. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease. Antimicrob Agents Chemother.1996 Feb;40(2):292-7.

[5]Caroline M Perry,et al. Nelfinavir: a review of its use in the management of HIV infection. Drugs.2005;65(15):2209-44.

[6]A Bardsley-Elliot,et al. Nelfinavir: an update on its use in HIV infection. Drugs. 2000 Mar;59(3):581-620.

Nelfinavir 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.81mL

1.76mL

0.88mL

17.61mL

3.52mL

1.76mL

Nelfinavir 技术信息

CAS号159989-64-7
分子式C32H45N3O4S
分子量 567.782
别名 奈非那韦 ;AG1341
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Inert atmosphere,2-8°C

溶解度

DMSO: 105 mg/mL(184.93 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。